TIME AND THEOPHYLLINE CONCENTRATION HELP EXPLAIN THE RECOVERY OF PEAK FLOW FOLLOWING ACUTE AIRWAYS OBSTRUCTION - POPULATION ANALYSIS OF A RANDOMIZED CONCENTRATION CONTROLLED TRIAL

被引:28
作者
HOLFORD, N
HASHIMOTO, Y
SHEINER, LB
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
[2] KYOTO UNIV,SCH PHARM,KYOTO,KYOTO,JAPAN
关键词
D O I
10.2165/00003088-199325060-00008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peak expiratory flow rate, adverse effects and serum theophylline concentration were measured during treatment of episodes of severe airways obstruction. 174 patients were randomised to target theophylline concentrations of 10 mg/L or 20 mg/L The recovery of peak flow rate towards normal values was explicable in terms of time and theophylline concentration using semiparametric and parametric nonlinear regression models. In the absence of theophylline, recovery takes place with a half-time of 16 hours. Theophylline is less effective in achieving recovery than the passage of time but achieves 50% of possible recovery at a concentration of 11 mg/L. The action of theophylline is most marked at the start of treatment. It may no longer have important beneficial effects after 72 hours. The incidence of adverse effects increased at theophylline concentrations >20 mg/L.
引用
收藏
页码:506 / 515
页数:10
相关论文
共 13 条
[1]  
Beal SL., 2022, NONMEM 7 4 USERS GUI
[2]  
Boor CD., 1978, PRACTICAL GUIDE SPLI
[3]   PULMONARY-FUNCTION IN THE ELDERLY - RESPONSE TO THEOPHYLLINE BRONCHODILATION [J].
CHANDLER, MHH ;
CLIFTON, GD ;
BURKI, NK ;
HUNT, BA ;
BLOUIN, RA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) :330-335
[4]   ROBUST LOCALLY WEIGHTED REGRESSION AND SMOOTHING SCATTERPLOTS [J].
CLEVELAND, WS .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1979, 74 (368) :829-836
[5]  
Cox D.R., 1974, THEORETICAL STAT
[6]   PREDNISOLONE PHARMACODYNAMICS ASSESSED BY INHIBITION OF THE MIXED LYMPHOCYTE-REACTION [J].
FREY, BM ;
FREY, FJ ;
HOLFORD, NHG ;
LOZADA, F ;
BENET, LZ .
TRANSPLANTATION, 1982, 33 (06) :578-584
[7]   THEOPHYLLINE TARGET CONCENTRATION IN SEVERE AIRWAYS OBSTRUCTION - 10 OR 20 MG/L - A RANDOMIZED CONCENTRATION-CONTROLLED TRIAL [J].
HOLFORD, N ;
BLACK, P ;
COUCH, R ;
KENNEDY, J ;
BRIANT, R .
CLINICAL PHARMACOKINETICS, 1993, 25 (06) :495-505
[8]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[9]   NONLINEAR MIXED EFFECTS MODELS FOR REPEATED MEASURES DATA [J].
LINDSTROM, MJ ;
BATES, DM .
BIOMETRICS, 1990, 46 (03) :673-687
[10]   RATIONAL INTRAVENOUS DOSES OF THEOPHYLLINE [J].
MITENKO, PA ;
OGILVIE, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (12) :600-603